ROCKVILLE, Md.--(BUSINESS WIRE)--Emergent BioSolutions Inc. (NYSE: EBS) announced today its financial results for the third quarter and nine months ended September 30, 2011.
Total revenues for the third quarter and first nine months of 2011 were $58.8 million and $165.4 million, respectively. Net income for the third quarter 2011 was $1.5 million, or $0.04 per basic share. For the first nine months of 2011, the Company realized a net loss of $5.6 million, or $0.16 per basic share.
Total revenues for the third quarter and first nine months of 2011 were $58.8 million and $165.4 million, respectively. Net income for the third quarter 2011 was $1.5 million, or $0.04 per basic share. For the first nine months of 2011, the Company realized a net loss of $5.6 million, or $0.16 per basic share.
